Fewer animal experiments in medicines testing: another success for the German federal institutes
On the occasion of the World Day for Laboratory Animals on 24 April, animal welfare organisations again demand a paradigm change and a withdrawal from animal experiments. In the case of regulatory animal experiments based on the legal requirements for the development and testing of medicines, the Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines (PEI) has successfully committed itself for achieving these goals for decades.
TAV, scientific advice and Brexit in the focus of the meeting between PEI and the BPI
No matter whether the subject concerns the Therapieallergeneverordnung (TAV, Therapy Allergens Regulation), offers for regulatory scientific advice, or Brexit: These topics have in common that they require all actors to proceed in a harmonised manner.
"The active dialogue with associations of the pharmaceutical industry optimises the interfaces for development, marketing authorisation, and testing, and in doing so – ensures safe and effective biomedicines in Germany and Europe", explained Professor Klaus Cichutek, president of the PEI.
Ten-year study proves: Official batch testing of vaccines remains indispensible
Official batch testing of vaccines before marketing is compulsory by law in Germany. However, is it still required in view of modern vaccine production? Experts at the Paul-Ehrlich-Institute have performed a study on this matter with focus on batch testing in influenza (flu) vaccines in Europe over a period of ten years.